AbbVie has made another bolt-on deal in the immunology and inflammation category, paying $48 million upfront for rights to an antibody in preclinical development at OSE Immunotherapeutics. There’s ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Ose Immunotherapeutics is prioritizing its lung cancer med Tedopi and shifting the strategy for its ulcerative colitis (UC) therapy lusvertikimab as the French biotech maps out a financially ...

OSE Immunotherapeutics (OTC:ORPOF) has announced a leadership transition following a decision by its board of directors. The company terminated Nicolas Poirier’s position as CEO and appointed Marc Le ...

Nantes, August 25, 2025, 7:00 a.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces the convening of its Annual General Shareholders’ Meeting, to be held on September 30, ...

OSE-CYTOMASK®, a new CIS-Demasking 1 cytokine bispecific technology. CLEC-1, a novel immune checkpoint target. NANTES, France – April 3, 2025, 6:00 p.m. CET - OSE Immunotherapeutics SA (ISIN: ...

NANTES, France - March 26, 2025, 6:15 p.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a biotech company dedicated to developing first-in-class therapies in immuno-oncology and ...

An Oxford-based venture capital firm has received £15 million in investment. Aviva Investors, the global asset management business of Aviva, has injected the money into Oxford Science Enterprises (OSE ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take a drubbing. But at OSE Immunotherapeutics, which aims to prevent cancers ...

Nigerian-Canadian R&B and Afro-soul singer Ose, has opened up about her music journey, inspirations, and creative process in an exclusive interview with DJ Slim on Daybreak Hitz. Ose, who started her ...

Built by formerly enslaved people, Freetown’s historic ‘bod oses’ now face an existential threat as foreign embassies move in. Jody Ray reports. On a humid March morning this year, police officers ...

The CEO at OSE Immunotherapeutics (EPA:OSE) has an important contribution to the development of a cure for cancer. “The lead compound or the lead program is a therapeutic cancer vaccine, meaning we ...